Israel stocks higher at close of trade; TA 35 up 0.05%

Investing.com – Israel stocks were higher after the close on Tuesday, as gains in the , and sectors led shares higher.

At the close in Tel Aviv, the rose 0.05%.

The best performers of the session on the were Teva Pharmaceutical Industries Ltd (TASE:), which rose 4.50% or 154 points to trade at 3573 at the close. Meanwhile, Liveperson (TASE:) added 2.94% or 420 points to end at 14690 and Delek Drilling LP (TASE:) was up 1.38% or 10 points to 766 in late trade.

The worst performers of the session were Delek Group (TASE:), which fell 3.60% or 1730 points to trade at 46320 at the close. Bazan Oil Refineries Ltd (TASE:) declined 3.00% or 4.9 points to end at 158.2 and Israel Corp (TASE:) was down 2.54% or 1510 points to 57890.

Rising stocks outnumbered declining ones on the Tel Aviv Stock Exchange by 219 to 168 and 36 ended unchanged.

Shares in Israel Corp (TASE:) fell to 52-week lows; falling 2.54% or 1510 to 57890.

Crude oil for March delivery was up 0.77% or 0.41 to $53.55 a barrel. Elsewhere in commodities trading, Brent oil for delivery in April rose 0.90% or 0.53 to hit $59.11 a barrel, while the February Gold Futures contract fell 0.57% or 8.95 to trade at $1568.45 a troy ounce.

USD/ILS was down 0.08% to 3.4542, while EUR/ILS fell 0.16% to 3.8028.

The US Dollar Index Futures was up 0.13% at 97.895.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.